Navigation Links
Trinity Biotech plc to Announce Second Quarter 2008 Financial Results on July 22, 2008
Date:7/15/2008

Conference Call Scheduled for July 22, 2008 at 11:00 am EASTERN

DUBLIN, Ireland, July 15 /PRNewswire-FirstCall/ -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter of fiscal year 2008 on Tuesday, July 22, 2008. The Company has scheduled a conference call for that same day, Tuesday, July 22, 2008, at 11:00am EDT (4:00pm BST) to discuss the results of the quarter.

Interested parties can access the call by dialing:

USA: 877-356-5706

International: +1-706-643-0580

A simultaneous webcast of the call can be accessed at: http://www.videonewswire.com/event.asp?id=50024

A replay of the call can be accessed until July 25, 2008 by dialing:

USA: 1-800-642-1687

International: +1-706-645-9291

Conference ID #: 56210288

The webcast of the call will be available for 30 days at: http://www.videonewswire.com/event.asp?id=50024

About Trinity Biotech plc

Headquartered in Wicklow, Ireland, Trinity Biotech develops, acquires, manufactures and markets over 500 diagnostic products for the point-of-care and clinical laboratory segments of the diagnostic market. The broad line of test kits are used to detect infectious diseases, sexually transmitted diseases, blood coagulation disorders, and autoimmune diseases. Trinity Biotech sells worldwide in over 80 countries through its own sales force and a network of international distributors and strategic partners.

For further information please see the company's website: http://www.trinitybiotech.com.

Contact:

Ms. Niamh Long Joe Diaz, Joe Dorame and Robert Blum

Trinity Biotech plc Lytham Partners, LLC

Investor Relations Officer 602-889-7900

(800) 603-8076


'/>"/>
SOURCE Trinity Biotech plc
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Video: Trinity Mother Frances Neurosurgeon Using New Disc System for Patients With Degenerative Diseases of the Neck
2. Oncolytics Biotech Inc. Treats 200th Cancer Patient in Clinical Studies with REOLYSIN(R)
3. WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology
4. Yongye Biotechnology International, Inc. Appoints New Independent Auditor
5. N.C. Biotech Center Launches Larger Loans
6. FDA Grants Epeius Biotechnologies Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas
7. Genetic Engineering & Biotechnology News reports on novel hit-to-lead drug discovery
8. Epeius Biotechnologies Tumor-Targeted Rexin-G Receives FDA Orphan Drug Designation for the Treatment of Osteosarcoma
9. Dietitian Mary Lee Chin Comments on Proven Value and Safety of Food Biotechnology in New Online Video
10. N.C. Biotechnology Center Launches Industrial Fellowship Program
11. ThirdBiotech Launches Research Institute to Promote Formation and Growth of Arizona-Based Biotech Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2016)... ... May 20, 2016 , ... The leading Regenerative Veterinary ... most experienced veterinary clients have treated over 100 of their own patients with the ... provide the highest level of care for their patients. , The veterinarians are ...
(Date:5/19/2016)... ... May 19, 2016 , ... Anton Paar USA, located in Ashland, Virginia is ... complete. The new structure adds a third office building to the current facilities. ... 2.4 acres of land, along with office space adjacent to the previous main building. ...
(Date:5/19/2016)... 2016 Regen BioPharma, ... RGBPP) announced today initiation of a preclinical development ... based cancer immunotherapeutic product leveraging its NR2F6 immunological ... a generation of cord blood derived killer cells ...  The product in development will be a "universal ...
(Date:5/18/2016)... 18, 2016 The Biotech industry continues ... mean that there are no opportunities ahead. Today, ActiveWallSt.com has ... THLD ), Seattle Genetics Inc. (NASDAQ: ... Ophthotech Corp. (NASDAQ: OPHT ). Sign up now ... http://www.activewallst.com/ Threshold Pharmaceuticals Inc.,s shares ...
Breaking Biology Technology:
(Date:5/20/2016)... , May 20, 2016  VoiceIt is excited ... with VoicePass. By working together, VoiceIt ...  Because VoiceIt and VoicePass take slightly different approaches ... increases both security and usability. ... about this new partnership. "This marketing ...
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
(Date:4/15/2016)...  A new partnership announced today will help ... in a fraction of the time it takes ... life insurance policies to consumers without requiring inconvenient ... Diagnostics, rapid testing (A1C, Cotinine and HIV) and ... weight, pulse, BMI, and activity data) available at ...
Breaking Biology News(10 mins):